Follow this exact reviewed peptide identity across selected source lanes.
Official matched intervention · Drug
Thymosin Beta 4 clinical trials
6 selected ClinicalTrials.gov records carrying the official matched intervention Thymosin Beta 4 (Drug). PeptideScanner includes the name only where it resolves exactly to the record’s reviewed peptide identity; it does not infer equivalence or treatment effect.
6 selected records.
1 profiles.
ClinicalTrials.gov intervention field.
Cross-source journeys
Explore connected peptide records
Across these connected profiles, PeptideScanner carries 25 selected PubMed records and 0 selected Drugs@FDA applications. That profile context is not a claim that those records concern this intervention or establish treatment effect.
Collection change ledger
Recently changed records on this intervention hub
These events come only from the exact registry records shown on this page. A matched intervention name does not establish equivalence, safety, effectiveness, or treatment effect.
ClinicalTrials.gov record NCT00382174
PeptideScanner retained ClinicalTrials.gov record NCT00382174 at 2026-11-16T01:44:56.605Z. Its registry update date was 2010-02-01, and PeptideScanner's reviewed identity mapping was thymosin-beta-4.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- February 1, 2010
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT00832091
PeptideScanner retained ClinicalTrials.gov record NCT00832091 at 2026-11-16T01:44:56.605Z. Its registry update date was 2010-03-30, and PeptideScanner's reviewed identity mapping was thymosin-beta-4.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- March 30, 2010
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT02597803
PeptideScanner retained ClinicalTrials.gov record NCT02597803 at 2026-11-16T01:44:56.605Z. Its registry update date was 2019-10-17, and PeptideScanner's reviewed identity mapping was thymosin-beta-4.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- October 17, 2019
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Thymosin beta-4 · 2026-11-05
ClinicalTrials.gov record NCT05555589
Completed at the retained observation.
Open attributed record →Thymosin beta-4 · 2026-10-21
ClinicalTrials.gov record NCT02974907
Completed at the retained observation.
Open attributed record →Thymosin beta-4 · 2026-08-28
ClinicalTrials.gov record NCT03937882
Completed at the retained observation.
Open attributed record →Thymosin beta-4 · 2019-10-17
ClinicalTrials.gov record NCT02597803
Completed at the retained observation.
Open attributed record →Thymosin beta-4 · 2010-03-30
ClinicalTrials.gov record NCT00832091
Completed at the retained observation.
Open attributed record →Thymosin beta-4 · 2010-02-01
ClinicalTrials.gov record NCT00382174
Completed at the retained observation.
Open attributed record →